Enveric Biosciences Inc (ENVB)
1.96 x 1 2.00 x 1
Pre-market by (Cboe BZX)
2.09 -1.81 (-46.41%) 01/31/25 [NASDAQ]
1.96 x 1 2.00 x 1
Pre-market 1.95 -0.14 (-6.70%) 05:16 ET
for Fri, Jan 31st, 2025
Results
download Want to compare other data? Select FieldsSymbol | ENVB | ATNF | REVB | ||
Company | Enveric Biosciences Inc | 180 Life Sciences Corp | Revelation Biosciences Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 2.40 | 1.4700 | 3.82 | ||
High | 2.40 | 1.5092 | 4.30 | ||
Low | 2.00 | 1.4000 | 3.68 | ||
Last | 2.09 | 1.4000 | 3.77 | ||
Change | -1.81 | -0.0400 | -0.05 | ||
% Change | -46.41% | -2.78% | -1.31% | ||
Volume | 1,575,800 | 81,600 | 309,600 | ||
20-Day Average Volume | 240,672 | 250,845 | 494,733 | ||
Previous Close | 3.90 | 1.4400 | 3.82 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | No | No | No | ||
Technicals | |||||
20-Day Moving Average | 5.19 | 1.5455 | 6.79 | ||
20-Day Raw Stochastic | 1.49% | 16.95% | 2.56% | ||
20-Day Relative Strength | 26.55% | 40.10% | 34.46% | ||
Weighted Alpha | -79.80 | -90.87 | -91.67 | ||
Today's Opinion | 88% Sell | 88% Sell | 100% Sell | ||
Previous Opinion | 88% Sell | 88% Sell | 100% Sell | ||
Last Month's Opinion | 100% Sell | 32% Sell | 100% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | -55.56% since 01/24/25 | -12.50% since 01/24/25 | -4.06% since 01/24/25 | ||
Low | 2.00 on 01/31/25 | 1.3000 on 01/30/25 | 3.34 on 01/30/25 | ||
High | 4.95 on 01/27/25 | 1.6400 on 01/27/25 | 4.70 on 01/29/25 | ||
1-Month | |||||
%Chg | -61.12% since 12/31/24 | -23.08% since 12/31/24 | -48.89% since 12/31/24 | ||
Low | 2.00 on 01/31/25 | 1.3000 on 01/30/25 | 3.34 on 01/30/25 | ||
High | 8.03 on 01/07/25 | 1.8900 on 01/02/25 | 20.16 on 01/02/25 | ||
3-Month | |||||
%Chg | -72.09% since 10/31/24 | -64.29% since 10/31/24 | -72.38% since 10/31/24 | ||
Low | 2.00 on 01/31/25 | 1.3000 on 01/30/25 | 3.34 on 01/30/25 | ||
High | 8.03 on 01/07/25 | 3.9815 on 11/01/24 | 20.16 on 01/02/25 | ||
6-Month | |||||
%Chg | -70.35% since 07/31/24 | -32.69% since 07/31/24 | -85.72% since 07/31/24 | ||
Low | 2.00 on 01/31/25 | 1.1600 on 10/08/24 | 3.34 on 01/30/25 | ||
High | 8.95 on 08/20/24 | 17.7500 on 10/16/24 | 56.00 on 08/21/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 1,418 | 1,438 | 1,011 | ||
Shares Outstanding, K | 678 | 1,027 | 268 | ||
Annual Sales | 0 | 0 | 0 | ||
Annual Net Income | -17,290,000 | -19,940,000 | -120,000 | ||
Last Quarter Sales | 0 | 0 | 0 | ||
Last Quarter Net Income | -2,080,000 | -840,000 | -2,240,000 | ||
60-Month Beta | 0.62 | 0.13 | 0.24 | ||
Per-Share Information | |||||
Most Recent Earnings | -0.24 on 11/14/24 | -0.85 on 11/14/24 | -13.44 on 11/08/24 | ||
Latest Earnings Date | 03/24/25 | 03/28/25 | 03/28/25 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |